UBC Faculty Research and Publications

Epinephrine autoinjectors available in Canada University of British Columbia. Therapeutics Initiative

Description

Therapeutics Letter 119 discusses epinephrine autoinjectors available in Canada. Conclusions People at risk for anaphylaxis in the outpatient setting should be advised to have access to at least two epinephrine autoinjectors especially when they are far from emergency medical care (home, travel, occupation, recreational activities). Oral medications such as antihistamines and corticosteroids are inadequate to treat rapidly-evolving, severe allergic reactions. Healthcare providers, especially community pharmacists, can access placebo demonstration epinephrine autoinjectors (trainers) to be used in patient teaching.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International